Menu
1-702-720-6310 info@microcapspecualtors.com

Biotech Stocks Rise After Trump’s Drug Price Risk Seems to Lessen – Bloomberg


Bloomberg

Biotech Stocks Rise After Trump’s Drug Price Risk Seems to Lessen
Bloomberg
“All of this has to do with politics,” said Brad Loncar, an independent biotechnology investor. “When negative things are being said, you’re going to have a lot of volume to the down side. When things are positive, you’re going to have a lot of volume

and more »

Search